Anibidiol

CPH expands its footprint with new product launch and entry into Eastern Europe

Finfeed Archived May 21, 2021

Creso Pharma (ASX: CPH) will enter the Polish animal health market after signing a Letter of Intent with Polvet Healthcare Teodorowski Spółka Jawna. It has also finalised the development of anibidiol® swine, a new and innovative hemp flour and oat bran based complementary feed product.

Creso teams up with CERES to distribute animal health products

Finfeed Archived Mar 01, 2021

Creso Pharma Ltd. (ASX: CPH) has inked a non-binding letter of intent with CBD and plant-based medicines provider CERES Natural Remedies.

Total combined orders for delivery for Creso Pharma (ASX: CPH) now over $1M

Finfeed Archived Jan 19, 2021

Creso Pharma Limited (ASX:CPH; FRA:1X8) continues to build a strong revenue platform for 2021, advising today that it has received two new purchase orders (POs) for its anibidiol® line of animal health products totalling A$247,826. Together, the total value of combined orders represents over A$1M.

Creso up 50% in a week with further catalysts imminent

Finfeed Archived Dec 02, 2020

Creso Pharma (ASX: CPH) has received three new purchase orders totalling $414,000 for its anibidiol® line of animal health products.